In the news:
Eli Lilly and Novo Want to Shake off Ozempic Copycats. Are They Ready To Meet Demand? - Here are Tuesday's biggest analyst calls: Apple, Microsoft, Palantir, Eli Lilly, Broadcom, Krispy Kreme, Live Nation & more - Americans seeking Eli Lilly and Novo Nordisk's weight-loss drugs turn to compounded market - Eli Lilly's Zepbound sales, Pfizer wants in on weight loss drugs, AbbVie's big deal: Pharma news round up - Stocks making the biggest moves premarket: Eli Lilly, Caterpillar, VinFast, Alphabet and more - Eli Lilly's quarter was messy. What to do with the stock is more clear-cut - Eli Lilly's slip does not mean the weight loss drug craze is over - Eli Lilly isn't selling as much Zepbound as expected -- and the stock is sinking - Shares in weight-loss drugmaker Eli Lilly tumble on disappointing sales - Eli Lilly to trial use of weight loss drugs to combat unemployment in UK
Summary
Eli Lilly is a company. It is located in the United States. The company is part of the Health Care sector.
Business see more
Eli Lilly is one of the companies in the United States, companies in Health Care and 3,466,499 companies in our database.
Stocks from Eli Lilly
Talking Points:
- Historic Medicines | Medicines | Eli Lilly and Company
- Lilly's heritage and values are the foundation of the company's promise to unite caring and discovery for people around the world. Learn more about historic medications at Lilly.
Learn more about talking points